Detalles de la búsqueda
1.
A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults.
J Infect Dis
; 222(10): 1681-1691, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687161
2.
Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial.
Hum Vaccin Immunother
; 17(5): 1463-1469, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33175600
3.
Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine.
Expert Rev Vaccines
; 19(11): 995-1010, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33297773
4.
Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial.
Hum Vaccin Immunother
; 16(6): 1464-1470, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31951771
5.
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
Pediatr Infect Dis J
; 38(6): 643-650, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116180
6.
Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
Vaccine
; 37(51): 7482-7492, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629570
7.
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
Vaccine
; 37(19): 2586-2599, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30975570
8.
Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
Vaccine
; 37(1): 176-186, 2019 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054160
9.
Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
Vaccine
; 36(28): 4102-4111, 2018 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29784470
10.
Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study.
Vaccine
; 36(5): 698-706, 2018 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29277353
11.
Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants.
Vaccine
; 35(35 Pt B): 4603-4611, 2017 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28729019
12.
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.
Vaccine
; 35(19): 2531-2542, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389097
13.
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
J Pediatric Infect Dis Soc
; 5(3): 237-248, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27125273
14.
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.
Pediatr Infect Dis J
; 34(11): 1230-5, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26284652
15.
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.
Vaccine
; 32(25): 3025-34, 2014 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24699466
16.
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.
Vaccine
; 32(50): 6838-46, 2014 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24607003
17.
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
Lancet Infect Dis
; 14(3): 205-12, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24287186
18.
Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2-dose or 3-dose priming and a booster dose in the first year of life.
Pediatr Infect Dis J
; 30(9): e155-63, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21572373
19.
A regularized method for selecting nested groups of relevant genes from microarray data.
J Comput Biol
; 16(5): 677-90, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19432538
20.
Characterization of the p53 response to oncogene-induced senescence.
PLoS One
; 3(9): e3230, 2008 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18800172
Resultados
1 -
20
de 20
1
Próxima >
>>